Trials / Completed
CompletedNCT02157753
Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center
Osteoporotic Fractures in a Swiss Trauma Center - Observational Study to Improve the Diagnosis and Management of and the Persistence to Therapy.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 478 (actual)
- Sponsor
- Kantonsspital Aarau · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
As a tertiary hospital the Traumatology department at the Kantonsspital Aarau looks after about 500 fracture patients hospitalized with an age over 50 years a year. First, we were interested in the effective rate of osteoporotic fractures in this cohort. As to this objective we offered subsequent diagnostics in suspected patients. 2012 we introduced a diagnostic pathway for every patient over 50 years of age with a fracture, including dual energy x-ray absorptiometry (DXA), a questionnaire about risk factors concerning osteoporosis and risk of fracture, the WHO Fracture Risk Assessment Tool (FRAX) and a laboratory workup focusing on this topic. Considering all these information we sent a detailed therapy-plan to the responsible General practitioner. The main goal of this study is to verify the persistence and compliance of the osteoporosis therapy 12-15 months after fracture and to clarify any obstacles potentially impeding therapy (prejudice, adverse events, contraindication overlooked, financial problems etc.). The investigators use a postal questionnaire provided to the patient and the general practitioner. Data collection is undertaken by a study nurse, in addition phoning for missing data by phone-call. With the aim to ameliorate the implementation of treatment, patients and general practitioners will be provided with the specifically tailored information found to be missing.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2015-10-01
- Completion
- 2015-12-01
- First posted
- 2014-06-06
- Last updated
- 2018-03-07
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02157753. Inclusion in this directory is not an endorsement.